BPG is committed to discovery and dissemination of knowledge
Retrospective Study
Copyright: ©Author(s) 2026.
World J Diabetes. Oct 15, 2026; 17(10): 124186
Published online Oct 15, 2026. doi: 10.4239/wjd.124186
Table 2 Vital sign and laboratory test result comparisons between severe and non-severe groups, n (%)/mean ± SD
Variables
Severe group (n = 60)
Non-severe group (n = 73)
t/Z/χ2
P value
HR, bpm119.20 ± 24.7098.44 ± 21.05-5.231< 0.001a
RR, bpm22.00 (18.00, 32.00)18.00 (18.00, 20.00)-3.272< 0.001a
WBC, × 109/L13.20 ± 7.9411.48 ± 6.24-1.4010.163
NLR, × 109/L9.33 (5.62, 14.17)6.83 (4.17, 9.78)-2.4420.015a
Hb, g/L156.97 ± 31.26156.74 ± 26.89-0.0510.964
RDW, %13.35 (12.88, 14.03)13.20 (12.80, 13.50)-1.7320.083
PLT, × 109/L190.00 (159.75, 239.50)240.00 (198.00, 292.00)-3.922< 0.001a
PT, second12.60 ± 1.4111.92 ± 1.13-3.0810.003a
ALT, U/L19.50 (11.90, 31.88)21.00 (15.80, 31.00)-0.9220.357
ALB, g/L34.49 ± 7.3739.28 ± 7.253.761< 0.001a
CRP, mg/L269.50 ± 147.01203.66 ± 133.49-2.7010.008a
PCT, ng/mL4.26 (0.97, 11.32)0.65 (0.16, 2.07)-4.322< 0.001a
Cr, μmol/L105.65 (54.22, 161.22)62.30 (49.90, 81.30)-3.952< 0.001a
Ca2+, mmol/L1.84 (1.49, 2.02)2.17 (2.00, 2.32)-5.102< 0.001a
Na+, mmol/L134.31 ± 5.99135.12 ± 5.060.8410.401
HbA1c, %9.83 ± 2.309.58 ± 1.83-0.6910.494
Chol, mmol/L4.10 (2.77, 10.52)4.75 (1.80, 8.81)-0.5120.611
TG, mmol/L19.06 (14.02, 27.02)16.21 (10.28, 24.59)-2.7220.006a
AMY, U/L442.70 (235.95, 777.73)159.00 (83.00, 403.10)-3.502< 0.001a
LPS, U/L734.12 (342.25, 1371.66)299.19 (97.00, 781.00)-3.752< 0.001a
FPG, mmol/L16.53 ± 5.0414.34 ± 3.89-2.7610.007a
RPG, mmol/L16.65 (13.47, 22.05)13.80 (11.90, 16.10)-3.752< 0.001a
pH7.36 (7.29, 7.40)7.37 (7.33, 7.41)-1.3220.188
Pleural effusion44 (73.33)27 (36.99)17.483< 0.001a
Abdominal effusion39 (65.00)37 (50.68)2.7630.097


Write to the Help Desk